Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors

NCT00301756 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

NIH

Sponsor class

Conditions

Fallopian Tube Carcinoma
Primary Peritoneal Carcinoma
Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor
Recurrent Ovarian Carcinoma
Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor
Stage III Ovarian Cancer
Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor
Stage IV Ovarian Cancer

Interventions

DRUG: Belinostat
OTHER: Laboratory Biomarker Analysis

Sponsor

National Cancer Institute (NCI)